h1

h2

h3

h4

h5
h6


001     1018608
005     20250919152337.0
024 7 _ |2 doi
|a 10.1007/s00259-025-07439-0
024 7 _ |2 ISSN
|a 1619-7070
024 7 _ |2 ISSN
|a 1619-7089
037 _ _ |a RWTH-2025-07891
041 _ _ |a English
082 _ _ |a 610
100 1 _ |0 P:(DE-HGF)0
|a Lütje, Susanne
|b 0
|e Corresponding author
245 _ _ |a Advancements in non-invasive visualization of the immune checkpoint TIGIT: a systematic review
|h online
260 _ _ |a Heidelberg [u.a.]
|b Springer-Verl.
|c 2025
336 7 _ |2 DRIVER
|a article
336 7 _ |2 DataCite
|a Output Types/Journal article
336 7 _ |0 PUB:(DE-HGF)16
|2 PUB:(DE-HGF)
|a Journal Article
|b journal
|m journal
|s 1758272157_3101334
336 7 _ |2 BibTeX
|a ARTICLE
336 7 _ |2 ORCID
|a JOURNAL_ARTICLE
336 7 _ |0 0
|2 EndNote
|a Journal Article
500 _ _ |a Opt-out-Artikel
536 _ _ |0 G:(GEPRIS)331065168
|a GRK 2375 - GRK 2375: Tumor-Targeted Drug Delivery (331065168)
|c 331065168
|x 0
536 _ _ |0 G:(GEPRIS)445703531
|a DFG project G:(GEPRIS)445703531 - KFO 5011: Integration neuer Methoden zur Verbesserung von translationaler Nierenforschung (445703531)
|c 445703531
|x 1
536 _ _ |0 G:(BMBF)16GW0319K
|a BMBF 16GW0319K - Wirkstofftransport: Paclitaxel-beladene polymere Mizellen (Pizellen) für die Behandlung von Triple-negativem Brustkrebs (PP-TNBC) - Von der Synthese über Wirksamkeit in die Klinik (16GW0319K)
|c 16GW0319K
|x 2
588 _ _ |a Dataset connected to CrossRef, Journals: publications.rwth-aachen.de
700 1 _ |a Schäfer, Laura
|b 1
700 1 _ |a Altunay, Betül
|b 2
700 1 _ |a Hertel, Fabian
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Morgenroth, Agnieszka
|b 4
700 1 _ |a Mottaghy, Felix M.
|b 5
773 _ _ |0 PERI:(DE-600)2098375-X
|a 10.1007/s00259-025-07439-0
|t European journal of nuclear medicine and molecular imaging
|x 1619-7070
|y 2025
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-HGF)0
|a RWTH Aachen
|b 0
|k RWTH
910 1 _ |0 I:(DE-588b)36225-6
|6 P:(DE-HGF)0
|a RWTH Aachen
|b 4
|k RWTH
915 1 _ |0 StatID:(DE-HGF)0031
|2 StatID
|a Peer reviewed article
|x 0
915 _ _ |0 StatID:(DE-HGF)3002
|2 StatID
|a DEAL Springer
|d 2024-12-05
|w ger
915 _ _ |0 StatID:(DE-HGF)3002
|2 StatID
|a DEAL Springer
|d 2024-12-05
|w ger
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
|b EUR J NUCL MED MOL I : 2022
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)0600
|2 StatID
|a DBCoverage
|b Ebsco Academic Search
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)0030
|2 StatID
|a Peer Review
|b ASC
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Clarivate Analytics Master Journal List
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)0160
|2 StatID
|a DBCoverage
|b Essential Science Indicators
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)1030
|2 StatID
|a DBCoverage
|b Current Contents - Life Sciences
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)1110
|2 StatID
|a DBCoverage
|b Current Contents - Clinical Medicine
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)0113
|2 StatID
|a WoS
|b Science Citation Index Expanded
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
|d 2024-12-05
915 _ _ |0 StatID:(DE-HGF)9905
|2 StatID
|a IF >= 5
|b EUR J NUCL MED MOL I : 2022
|d 2024-12-05
920 1 _ |0 I:(DE-82)532500-2_20140620
|k 532500-2 ; 934510
|l Klinik und Lehrstuhl für Nuklearmedizin
|x 0
980 _ _ |a journal
980 _ _ |a VDBINPRINT
980 _ _ |a I:(DE-82)532500-2_20140620
980 _ _ |a UNRESTRICTED


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21